01 6CATALYST PHARMS
01 18334279
02 110857161
03 111382922
04 111471471
05 111690853
06 111833159
01 1Y
02 5Blank
01 3Y
02 3Blank
01 32029-05-28
02 12033-03-07
03 12040-03-17
04 12040-07-16
Patent Expiration Date : 2033-03-07
US Patent Number : 11690853
Drug Substance Claim :
Drug Product Claim :
Application Number : 215239
Patent Use Code : U-3747
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-07
Patent Expiration Date : 2040-03-17
US Patent Number : 11471471
Drug Substance Claim :
Drug Product Claim :
Application Number : 215239
Patent Use Code : U-3747
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2040-03-17
Patent Expiration Date : 2029-05-28
US Patent Number : 10857161
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215239
Patent Use Code : U-3747
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-28
Patent Expiration Date : 2029-05-28
US Patent Number : 8334279
Drug Substance Claim :
Drug Product Claim :
Application Number : 215239
Patent Use Code : U-3747
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-28
Patent Expiration Date : 2029-05-28
US Patent Number : 11833159
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215239
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-28
Patent Expiration Date : 2040-07-16
US Patent Number : 11382922
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 215239
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2040-07-16
